ArticleBMJ open2021

Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant

Alicia Marín-Candón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.